180 Life Sciences (ATNF) Short Interest Ratio & Short Volume $2.98 -0.12 (-3.87%) As of 08/27/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock 180 Life Sciences Short Interest Data180 Life Sciences (ATNF) has a short interest of 1.14 million shares, representing 30.55% of the float (the number of shares available for trading by the public). This marks a 1,681.25% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 22.03 million shares to cover all short positions.Current Short Interest1,140,000 sharesPrevious Short Interest64,000 sharesChange Vs. Previous Month+1,681.25%Dollar Volume Sold Short$3.74 millionShort Interest Ratio0.5 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares6,039,000 sharesShort Percent of Float30.55%Today's Trading Volume12,996,312 sharesAverage Trading Volume22,030,452 sharesToday's Volume Vs. Average59% Short Selling 180 Life Sciences? Sign up to receive the latest short interest report for 180 Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATNF Short Interest Over TimeATNF Days to Cover Over TimeATNF Percentage of Float Shorted Over Time 180 Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20251,140,000 shares $3.74 million +1,681.3%30.5%0.5 $3.28 7/15/202564,000 shares $57.22 thousand -0.3%1.9%0 $0.89 6/30/202564,200 shares $59.59 thousand +66.8%2.2%0.5 $0.93 6/15/202538,500 shares $37.77 thousand -47.0%1.3%0.3 $0.98 5/31/202572,600 shares $74.05 thousand -21.3%13.1%0.6 $1.02 5/15/202592,200 shares $107.87 thousand +4.0%22.3%0.6 $1.17 4/30/202588,700 shares $78.94 thousand -25.7%21.5%0.6 $0.89 4/15/2025119,300 shares $106.18 thousand +107.8%13.0%1.3 $0.89 3/31/202557,400 shares $58.84 thousand +2.5%4.2%0.4 $1.03 3/15/202556,000 shares $59.92 thousand +67.2%4.1%0.1 $1.07 Get the Latest News and Ratings for ATNF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/202533,500 shares $39.20 thousand +29.3%2.4%0.1 $1.17 2/15/202525,900 shares $34.45 thousand -50.4%1.5%0.1 $1.33 1/31/202552,200 shares $73.08 thousand -63.2%3.1%0.1 $1.40 1/15/2025141,800 shares $232.55 thousand +11.7%8.4%0.2 $1.64 12/31/2024126,900 shares $230.96 thousand -21.1%7.6%0.1 $1.82 12/15/2024160,800 shares $310.34 thousand +148.2%31.4%0.1 $1.93 11/30/202464,800 shares $144.50 thousand -28.6%13.2%0 $2.23 11/15/202490,800 shares $227 thousand -34.9%18.5%0 $2.50 10/31/2024139,400 shares $546.45 thousand +77.1%28.5%0.1 $3.92 10/15/202478,700 shares $119.62 thousand +7.4%16.1%0 $1.52 9/30/202473,300 shares $123.88 thousand +21.0%14.1%0.8 $1.69 9/15/202460,600 shares $109.69 thousand +78.8%11.7%0.1 $1.81 8/31/202433,900 shares $61.36 thousand +5.3%6.5%0.1 $1.81 8/15/202432,200 shares $60.54 thousand -29.7%6.2%0.1 $1.88 7/31/202445,800 shares $95.26 thousand -67.5%8.8%0.1 $2.08 7/15/2024140,800 shares $285.82 thousand +249.4%27.2%0.2 $2.03 6/30/202440,300 shares $66.50 thousand +13.2%7.8%0.1 $1.65 6/15/202435,600 shares $55.18 thousand -19.8%6.9%0.3 $1.55 5/31/202444,400 shares $71.93 thousand +156.7%8.6%0.3 $1.62 5/15/202417,300 shares $33.56 thousand -36.9%3.4%0.1 $1.94 4/30/202427,400 shares $58.91 thousand +60.2%5.3%0.3 $2.15 4/15/202417,100 shares $34.54 thousand -59.7%3.3%0.2 $2.02 3/31/202442,400 shares $98.79 thousand -31.4%8.4%0.4 $2.33 3/15/202461,800 shares $216.30 thousand +309.3%12.2%0.6 $3.50 2/29/202415,100 shares $53.15 thousand -95.6%3.0%0.2 $3.52 2/15/2024342,100 shares $1.36 million -22.8%3.6%0.3 $3.99 1/31/2024443,300 shares $94.87 thousand -61.8%4.6%0.4 $0.21 1/15/20241,160,000 shares $234.55 thousand +195.7%12.2%1 $0.20 12/31/2023392,300 shares $83.76 thousand -32.9%4.1%0.4 $0.21 12/15/2023584,700 shares $109.92 thousand -4.0%6.2%1 $0.19Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 11/30/2023608,900 shares $165.01 thousand +281.3%8.8%1.2 $0.27 11/15/2023159,700 shares $57.48 thousand +26.1%2.3%1.2 $0.36 10/31/2023126,700 shares $54.48 thousand +21.2%2.3%0.9 $0.43 10/15/2023104,500 shares $58.51 thousand -37.3%1.9%0.3 $0.56 9/30/2023166,700 shares $102.10 thousand +64.7%3.0%0.5 $0.61 9/15/2023101,200 shares $83.71 thousand -30.1%1.8%0.3 $0.83 8/31/2023144,800 shares $96.58 thousand -77.1%2.6%0.5 $0.67 8/15/2023632,100 shares $453.85 thousand +3,108.6%11.2%1.9 $0.72 7/31/202319,700 shares $18.52 thousand -34.8%0.4%0 $0.94 7/15/202330,200 shares $31.41 thousand -46.4%0.6%0.1 $1.04 6/30/202356,300 shares $65.87 thousand -52.3%1.1%0.1 $1.17 6/15/2023118,000 shares $136.88 thousand -27.4%2.4%0.1 $1.16 5/31/2023162,500 shares $185.25 thousand +70.3%3.4%0.2 $1.14 5/15/202395,400 shares $98.26 thousand -13.2%2.0%0.1 $1.03 4/30/2023109,900 shares $126.39 thousand -51.7%2.4%0.2 $1.15 4/15/2023227,500 shares $282.10 thousand +106.6%7.2%0.2 $1.24 3/31/2023110,100 shares $198.18 thousand +56.0%3.5%0.1 $1.80 3/15/202370,600 shares $146.14 thousand -59.2%4.6%0 $2.07 2/28/2023173,000 shares $496.51 thousand -7.2%11.2%0 $2.87 2/15/2023186,400 shares $561.06 thousand -52.7%11.2%0 $3.01 1/31/2023393,900 shares $1.31 million -26.6%23.6%0.1 $3.33 1/15/2023536,900 shares $1.99 million +3.0%32.2%0.1 $3.71 12/30/2022521,100 shares $1.77 million +1,060.6%31.2%0.1 $3.39 12/15/202244,900 shares $243.99 thousand -94.9%2.8%0.1 $5.43 11/30/2022874,900 shares $367.46 thousand -0.2%N/A4.4 $0.42 11/15/2022876,800 shares $380.88 thousand -3.4%N/A4.6 $0.43 10/31/2022907,300 shares $424.80 thousand -11.1%N/A4.2 $0.47 10/15/20221,020,000 shares $520.40 thousand +1.0%N/A4.9 $0.51 9/30/20221,010,000 shares $671.65 thousand +2.0%N/A4.7 $0.67 9/15/2022990,000 shares $802.00 thousand -2.0%N/A5.6 $0.81 8/31/20221,010,000 shares $859.91 thousand +9.8%N/A4.7 $0.85 8/15/2022919,500 shares $1.05 million -1.7%N/A3.4 $1.14 7/31/2022935,700 shares $1.02 million +3.9%N/A3.3 $1.09 7/15/2022900,500 shares $1.03 million -8.0%N/A2 $1.14 6/30/2022978,400 shares $829.68 thousand -13.4%N/A2.1 $0.85 6/15/20221,130,000 shares $998.92 thousand -18.7%N/A2.3 $0.88 5/31/20221,390,000 shares $2.25 million -0.7%N/A3.2 $1.62 5/15/20221,400,000 shares $1.76 million +5.3%N/A3.6 $1.26 4/30/20221,330,000 shares $2.82 million -1.5%N/A3.4 $2.12 4/15/20221,350,000 shares $2.65 million -6.3%N/A4.7 $1.96 3/31/20221,440,000 shares $3.73 million -4.0%N/A4.6 $2.59 3/15/20221,500,000 shares $3.87 million +5.6%N/A4.2 $2.58 2/28/20221,420,000 shares $4.53 million -6.6%N/A2.9 $3.19 2/15/20221,520,000 shares $4.97 million +13.4%N/A1.8 $3.27 1/31/20221,340,000 shares $3.83 million -8.8%N/A1.4 $2.86 1/15/20221,470,000 shares $4.47 million -7.0%N/A1.5 $3.04 12/31/20211,580,000 shares $6.16 million -18.1%N/A1.6 $3.90 12/15/20211,930,000 shares $7.86 million +37.9%N/A2 $4.07 11/30/20211,400,000 shares $8.93 million +2.2%N/A1.3 $6.38 11/15/20211,370,000 shares $5.86 million -16.0%N/A1.8 $4.28Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here 10/29/20211,630,000 shares $8.26 million +16.4%N/A2.4 $5.07 10/15/20211,400,000 shares $7.85 million -4.8%N/A1.9 $5.61 9/30/20211,470,000 shares $7.95 million -33.8%N/A2.1 $5.41 9/15/20212,220,000 shares $14.65 million +14.4%N/A3.3 $6.60 8/31/20211,940,000 shares $11.43 million +116.6%N/A3.9 $5.89 8/13/2021895,800 shares $6.96 million -60.5%N/A2 $7.77 7/30/20212,270,000 shares $17.18 million +3.2%20.3%5.7 $7.57 7/15/20212,200,000 shares $20.17 million -0.5%19.7%5.7 $9.17 6/30/20212,210,000 shares $22.10 million -1.3%24.2%1.7 $10.00 6/15/20212,240,000 shares $22.92 million +2.8%24.6%1 $10.23 5/28/20212,180,000 shares $18.62 million -15.5%23.9%0.9 $8.54 5/14/20212,580,000 shares $17.67 million -9.8%28.3%1 $6.85 4/30/20212,860,000 shares $29.66 million -5.6%31.4%1.1 $10.37 4/15/20213,030,000 shares $31.69 million +25.7%33.2%1 $10.46 3/31/20212,410,000 shares $14.80 million +6.2%26.4%0.8 $6.14 3/15/20212,270,000 shares $14.48 million +6.1%83.5%1.3 $6.38 2/26/20212,140,000 shares $9.44 million +364.0%78.7%1.3 $4.41 2/12/2021461,200 shares $2.73 million +54.6%17.0%0.3 $5.91 1/29/2021298,300 shares $1.04 million -1.8%11.0%0.2 $3.48 1/15/2021303,900 shares $948.17 thousand No Change11.2%0.3 $3.12 ATNF Short Interest - Frequently Asked Questions What is 180 Life Sciences' current short interest? Short interest is the volume of 180 Life Sciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 1,140,000 shares of ATNF short. 30.55% of 180 Life Sciences' shares are currently sold short. Learn More on 180 Life Sciences' current short interest. What is a good short interest percentage for 180 Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 30.55% of 180 Life Sciences' floating shares are currently sold short. Is 180 Life Sciences' short interest increasing or decreasing? 180 Life Sciences saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 1,140,000 shares, an increase of 1,681.3% from the previous total of 64,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does 180 Life Sciences' short interest compare to its competitors? 30.55% of 180 Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 180 Life Sciences: Lifevantage Corporation (23.30%), Nkarta, Inc. (12.43%), Nuvectis Pharma, Inc. (7.66%), Journey Medical Corporation (13.91%), Greenwich LifeSciences, Inc. (17.36%), Cardiff Oncology, Inc. (30.68%), Cellectis S.A. (0.38%), MEI Pharma, Inc. (34.18%), Eledon Pharmaceuticals, Inc. (8.32%), Black Diamond Therapeutics, Inc. (12.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short 180 Life Sciences stock? Short selling ATNF is an investing strategy that aims to generate trading profit from 180 Life Sciences as its price is falling. ATNF shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 180 Life Sciences? A short squeeze for 180 Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNF, which in turn drives the price of the stock up even further. How often is 180 Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNF, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Lifevantage Short Squeeze Nkarta Short Squeeze Nuvectis Pharma Short Squeeze Journey Medical Short Squeeze Greenwich LifeSciences Short Squeeze Cardiff Oncology Short Squeeze Cellectis Short Squeeze MEI Pharma Short Squeeze Eledon Pharmaceuticals Short Squeeze Black Diamond Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATNF) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access